OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.400
-0.040 (-2.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.400
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$209,730
Profits / Employee
-$727,854
Market Cap
202.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MacroGenics | 293 |
| Voyager Therapeutics | 141 |
| MediWound | 121 |
| Nkarta | 108 |
| Caribou Biosciences | 97 |
| Keros Therapeutics | 78 |
| ALX Oncology Holdings | 43 |
OABI News
- 4 days ago - OmniAb to Participate in Three Upcoming Investor Conferences - Business Wire
- 7 days ago - OmniAb to Report First Quarter 2026 Financial Results on May 7 - Business Wire
- 7 weeks ago - OmniAb Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Business Wire
- 2 months ago - OmniAb to Participate at the Leerink Partners Global Healthcare Conference - Business Wire
- 2 months ago - OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 - Business Wire
- 4 months ago - OmniAb Transcript: Investor Update - Transcripts
- 4 months ago - Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies - Business Wire